Literature DB >> 19745505

Prevalence and determinants of nonadherence to highly active antiretroviral therapy among people living with HIV/AIDS in Ibadan, Nigeria.

Samuel A Olowookere1, Akinola A Fatiregun, Joshua O Akinyemi, Afolabi E Bamgboye, Gordon K Osagbemi.   

Abstract

OBJECTIVE: To determine the level of nonadherence to highly active antiretroviral therapy (HAART) and to explore the association of factors militating against adherence and nonadherence to therapy among people living with HIV/AIDS (PLWHA) at an Antiretroviral Clinic in Ibadan, Nigeria.
DESIGN: A cross-sectional survey was employed to determine the prevalence of nonadherence.
METHODOLOGY: A structured interviewer-administered questionnaire was applied to consecutive PLWHA who had been on therapy for a minimum of three months. The completed questionnaires were entered into a computer and analyzed. Multivariate logistic regression was used to determine factors associated with nonadherence.
RESULTS: Three hundred and eighteen people living with HIV/AIDS completed the questionnaire. Their mean age was 39.1+/-9.6 years. There were 173 (54.4%) females and 145 (45.6%) males. The median duration on HAART was 19 months (Range 3 to 28 months) and the prevalence of nonadherence was 118 (37.1%) using the less than 95% adherence profile. About a third (31.5%) of those missing therapy reportedly missed their medication because of fasting. Multiple logistic regression analysis revealed that patients who felt healthy or simply forgot to take their drugs and those not willing to disclose their HIV status were independently, significantly associated with less than 95% adherence.
CONCLUSION: The study showed that nonadherence to HAART is a problem in the ARV clinic and that the feeling of being healthy, forgetfulness, and unwillingness to disclose HIV status by PLWHA were significant barriers to adherence. Efforts to improve adherence in the clinic will have to address these issues among others.

Entities:  

Mesh:

Year:  2008        PMID: 19745505     DOI: 10.3855/jidc.199

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  28 in total

1.  Motivational groups support adherence to antiretroviral therapy and use of risk reduction behaviors in HIV positive Nigerian women: a pilot study.

Authors:  Marcia McDonnell Holstad; James E Essien; Ernest Ekong; Melinda Higgins; Ilya Teplinskiy; Modupe Falilatu Adewuyi
Journal:  Afr J Reprod Health       Date:  2012-09

Review 2.  Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.

Authors:  Alexander J Lankowski; Mark J Siedner; David R Bangsberg; Alexander C Tsai
Journal:  AIDS Behav       Date:  2014-07

3.  Return to normal life after AIDS as a reason for lost to follow-up in a community-based antiretroviral treatment program.

Authors:  Stella T Alamo; Robert Colebunders; Joseph Ouma; Pamela Sunday; Glenn Wagner; Fred Wabwire-Mangen; Marie Laga
Journal:  J Acquir Immune Defic Syndr       Date:  2012-06-01       Impact factor: 3.731

4.  A binational study of patient-initiated changes to antiretroviral therapy regimen among HIV-positive Latinos living in the Mexico-U.S. border region.

Authors:  María Luisa Zúñiga; Fátima Muñoz; Justine Kozo; Estela Blanco; Rosana Scolari
Journal:  AIDS Behav       Date:  2012-08

5.  The role of maternal, health system, and psychosocial factors in prevention of mother-to-child transmission failure in the era of programmatic scale up in western Kenya: a case control study.

Authors:  Maricianah Onono; Kevin Owuor; Janet Turan; Elizabeth A Bukusi; Glenda E Gray; Craig R Cohen
Journal:  AIDS Patient Care STDS       Date:  2015-03-04       Impact factor: 5.078

6.  Predictors of poor adherence among people on antiretroviral treatment in Cape Town, South Africa: a case-control study.

Authors:  Sarah Dewing; Cathy Mathews; Mark Lurie; Ashraf Kagee; Trishanta Padayachee; Carl Lombard
Journal:  AIDS Care       Date:  2015-01-03

7.  Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria.

Authors:  B A Afolabi; M O Afolabi; A A Afolabi; M A Odewale; S A Olowookere
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

8.  Adherence to antiretroviral therapy (ART) during the early months of treatment in rural Zambia: influence of demographic characteristics and social surroundings of patients.

Authors:  Yuri Sasaki; Kazuhiro Kakimoto; Christopher Dube; Izukanji Sikazwe; Crispin Moyo; Gardner Syakantu; Kenichi Komada; Shinsuke Miyano; Naoko Ishikawa; Kiyoshi Kita; Ichiro Kai
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-12-28       Impact factor: 3.944

9.  Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice.

Authors:  Emmanuel Monjok; Andrea Smesny; Ita B Okokon; Osaro Mgbere; E James Essien
Journal:  HIV AIDS (Auckl)       Date:  2010-03-30

10.  Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women.

Authors:  S O Ekama; E C Herbertson; E J Addeh; C V Gab-Okafor; D I Onwujekwe; F Tayo; O C Ezechi
Journal:  J Pregnancy       Date:  2012-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.